| Literature DB >> 32875897 |
Kunal Varshneya1, Zachary A Medress1, Martin N Stienen1,2,3, Jay Nathan4, Allen Ho1, Arjun V Pendharkar1, Sheri Loo1, Jessica Aikin1, Gordon Li1, Atman Desai1, John K Ratliff1, Anand Veeravagu1.
Abstract
STUDYEntities:
Keywords: anterior; cervical; deformity; posterior; spine; surgery; surgical approach type
Year: 2020 PMID: 32875897 PMCID: PMC8165914 DOI: 10.1177/2192568220915717
Source DB: PubMed Journal: Global Spine J ISSN: 2192-5682
Figure 1.Payments for cervical fusion by type.
Demographics (P Value Threshold 0.05/12 = .004).a
| Variables | Anterior, N = 4819 | Posterior, N = 1241 | Circumferential, N = 515 |
|
|---|---|---|---|---|
| Age, mean (SD) | 54.5 (10.9) | 58.6 (13.5) | 57.1 (10.4) |
|
| Female, n (%) | 3125 (64.9) | 643 (51.8) | 280 (54.4) |
|
| CHF, n (%) | 361 (7.5) | 179 (14.4) | 73 (14.2) |
|
| Hypertension, n (%) | 2087 (43.3) | 658 (53.0) | 278 (54.0) |
|
| Diabetes, n (%) | 1013 (21.0) | 335 (27.0) | 120 (23.0) |
|
| Liver disease, n (%) | 331 (6.9) | 108 (8.7) | 45 (8.7) | .0403 |
| Cardiac arrhythmia, n (%) | 695 (14.4) | 259 (20.9) | 114 (22.4) |
|
| Tobacco use, n (%) | 1438 (29.9) | 378 (30.5) | 175 (34.0) | .1495 |
| Alcohol use, n (%) | 101 (2.1) | 31 (2.5) | 14 (2.7) | .5033 |
| Osteoporosis, n (%) | 952 (19.8) | 267 (21.5) | 115 (22.5) | .1893 |
| CCI score (mean) | 0.22 (0.6) | 0.38 (0.8) | 0.33 (0.7) |
|
| Region |
| |||
| Northeast | 580 (12.0) | 239 (19.3) | 105 (20.4) | |
| North Central | 1006 (20.9) | 273 (22.0) | 94 (18.3) | |
| South | 2079 (43.1) | 479 (38.6) | 202 (39.2) | |
| West | 1054 (21.9) | 221 (17.8) | 99 (19.2) | |
| Unknown | 100 (2.1) | 29 (2.3) | 15 (2.3) |
Abbreviations: CHF, congestive heart failure; CCI, Charlson Comorbidity Index.
aBoldface indicates statistical significance at an alpha level P < .05.
Ninety-Day Complications (P Value Threshold 0.05/14 = .003).a
| Variables, n (%) | Anterior, N = 4819 | Posterior, N = 1241 | Circumferential, N = 515 |
|
|---|---|---|---|---|
| Any complication | 892 (18.5) | 453 (36.7) | 241 (46.9) |
|
| Delirium | 117 (2.4) | 85 (6.9) | 40 (7.8) |
|
| Deep vein thrombosis | 15 (0.3) | 7 (0.6) | 4 (0.8) | .1585 |
| Dysrhythmia | 27 (0.6) | 19 (1.5) | 2 (0.4) |
|
| Hematoma | 61 (1.3) | 40 (3.2) | 12 (2.3) |
|
| Pulmonary embolism | 31 (0.6) | 21 (1.7) | 8 (1.6) |
|
| Posthemorrhagic anemia | 141 (2.9) | 122 (9.9) | 68 (13.3) |
|
| Wound dehiscence | 22 (0.5) | 42 (3.4) | 17 (3.3) |
|
| MI | 72 (1.5) | 32 (1.6) | 17 (3.3) |
|
| Wound infection | 55 (1.1) | 78 (6.3) | 30 (5.8) |
|
| Other wound complication | 16 (0.3) | 21 (1.7) | 11 (2.1) |
|
| Pneumonia | 97 (2.0) | 52 (4.2) | 38 (7.4) |
|
| Pulmonary complication | 219 (4.5) | 124 (10.1) | 102 (19.8) |
|
| ARDS | 35 (0.7) | 13 (1.1) | 10 (2.0) | .0153 |
Abbreviations: MI, myocardial infarction; ARDS, acute respiratory distress syndrome.
aBoldface indicates statistical significance at an alpha level P < .05.
Quality Outcomes (P Value Threshold 0.05/5 = .01).a
| Variables | Anterior, N = 4819 | Posterior, N = 1241 | Circumferential, N = 515 |
|
|---|---|---|---|---|
| Length of stay, mean (SD) | 2.1 (2.7) | 4.4 (4.3) | 4.9 (4.7) |
|
| Reoperations—90 days, n (%) | ||||
| Any | 1417 (29.4) | 333 (26.9) | 206 (40.0) |
|
| Anterior | 1319 (27.4) | 44 (3.6) | 69 (13.4) |
|
| Posterior | 119 (2.5) | 296 (23.9) | 141 (27.4) |
|
| Readmissions—90 days, n (%) | 391 (8.1) | 212 (17.1) | 89 (17.4) |
|
aBoldface indicates statistical significance at an alpha level P < .05.
Cost Outcomes (P Value Threshold 0.05/5 = .0125).a
| Variables | Anterior, N = 4819 | Posterior, N = 1241 | Circumferential, N = 515 |
|
|---|---|---|---|---|
| Index hospitalization costs (mean) | ||||
| Physician payments | $8519 | $9439 | $14 865 |
|
| Hospital payments | $29 120 | $52 838 | $73 034 |
|
| Total payments | $41 855 | $67 481 | $95 366 |
|
| 90-day total payments | $44 848 | $74 556 | $101 049 |
|
aBoldface indicates statistical significance at an alpha level P < .05.
Demographics for PSM Cohort (P Value = 0.05/12 = .004).
| Variables | Anterior, N = 2313 | Posterior, N = 1227 |
|
|---|---|---|---|
| Age, mean (SD) | 57.7 (11.3) | 58.6 (13.5) | .1145 |
| Female, n (%) | 1192 (51.8) | 641 (52.2) | .7811 |
| CHF, n (%) | 284 (12.3) | 172 (14.0) | .1415 |
| Hypertension, n (%) | 1200 (51.8) | 645 (52.8) | .6972 |
| Diabetes, n (%) | 586 (25.8) | 326 (26.6) | .4244 |
| Liver disease, n (%) | 173 (7.5) | 106 (8.6) | .2231 |
| Cardiac arrhythmia, n (%) | 418 (18.1) | 253 (20.6) | .0657 |
| Tobacco use, n (%) | 690 (29.8) | 374 (30.5) | .6884 |
| Alcohol use, n (%) | 52 (2.3) | 30 (2.4) | .711 |
| Osteoporosis, n (%) | 500 (21.2) | 266 (21.6) | .966 |
| CCI score, mean (SD) | 0.33 (0.7) | 0.37 (0.78) | .0837 |
Abbreviations: CHF, congestive heart failure; CCI, Charlson Comorbidity Index.
Ninety-Day Complications for PSM Cohort (P Value Threshold 0.05/14 = .003).a
| Variables, n (%) | Anterior, n = 2313 | Posterior, n = 1227 |
| OR (95% CI) |
|---|---|---|---|---|
| Any complication | 514 (22.3) | 446 (36.5) |
| 2.0 (1.7-2.4) |
| Delirium | 66 (2.9) | 84 (6.9) |
| 2.5 (1.8-3.5) |
| Deep vein thrombosis | 11 (0.5) | 7 (0.6) | .7025 | 1.2 (0.5-3.1) |
| Dysrhythmia | 20 (0.9) | 18 (1.5) | .0967 | 1.7 (0.9-3.2) |
| Hematoma | 26 (1.1) | 39 (3.2) |
| 2.9 (1.8-4.8) |
| Pulmonary embolism | 20 (0.9) | 21 (1.7) | .0246 | 2.0 (1.1-3.7) |
| Posthemorrhagic anemia | 84 (3.6) | 122 (10.0) |
| 2.9 (2.2-3.9) |
| Wound dehiscence | 9 (0.4) | 41 (3.4) |
| 8.8 (4.3-18.3) |
| MI | 60 (2.6) | 30 (2.5) | .7955 | 0.9 (0.6-1.5) |
| Wound infection | 17 (0.7) | 75 (6.1) |
| 8.8 (5.2-15.0) |
| Other wound complication | 10 (0.4) | 20 (1.6) |
| 3.8 (1.8-8.2) |
| Pneumonia | 66 (2.9) | 51 (4.2) | .0381 | 1.5 (1.0-2.1) |
| Pulmonary complication | 150 (6.5) | 121 (9.9) |
| 1.58 (1.2-2.0) |
| ARDS | 23 (1.0) | 13 (1.1) | .8497 | 1.1 (0.5-2.1) |
Abbreviations: OR, odds ratio; CI, confidence interval; MI, myocardial infarction; ARDS, acute respiratory distress syndrome.
aBoldface indicates statistical significance at an alpha level P < .05.
Quality Outcomes for PSM Cohort (P Value Threshold 0.05/5 = .01).a
| Variables | Anterior, n = 2313 | Posterior, n = 1227 |
| OR (95% CI) |
|---|---|---|---|---|
| Length of stay, mean (SD) | 2.35 (3.3) | 4.4 (4.1) |
| n/a |
| Reoperations—90 days, n (%) | ||||
| Any | 711 (30.7) | 330 (26.9) | .0173 | 0.9 (0.7-1.0) |
| Anterior | 647 (28.0) | 44 (3.6) |
| 0.1 (0.1-0.1) |
| Posterior | 73 (3.2) | 293 (23.9) |
| 9.6 (7.4-12.6) |
| Readmissions—90 days | 219 (9.5) | 210 (17.1) |
| 2.0 (1.6-2.4) |
| Index Hospitalization Costs (Mean) |
| |||
| Physician payments | $8584 | $9480 | .0371 | |
| Hospital payments | $30 376 | $52 641 |
| |
| Total payments | $43 244 | $67 349 |
| |
| 90-day total payments | $46 600 | $74 399 |
| |
Abbreviations: OR, odds ratio; CI, confidence interval.
aBoldface indicates statistical significance at an alpha level P < .05.